RSS The Lancet Infectious Diseases
哪吒推荐该订阅
简介:the lancet infectious diseases rss feed: current issue. the lancet infectious diseases is an international peer-reviewed journal that publishes reviews, commentaries, and news on any topic connected with infectious diseases. the journal has an impact factor of 10.01, the highest of any journal in the field of infectious diseases.
原站:http://www.thelancet.com/journals/laninf
指数:
点击立即订阅,“The Lancet Infectious...”的内容有更新,哪吒第一时间提醒您
“The Lancet Infectious Diseases”的内容更新
累计:831 篇(自 2009-04-22 起)
更新:约6篇/周,最后更新20 天前
The Lancet Infectious Diseases
on oct 25, 2011, eli lilly announced the voluntarily withdrawal from the market of drotrecogin alfa (activated), marketed as xigris, a drug licensed for the treatment of severe sepsis. drotrecogin alfa, a recombinant form of human activated protein c with anticoagulant and anti-inflammatory activity, was the only pharmaceutical available designed specifi... (20 天前)
The Lancet Infectious Diseases
combination antiretroviral therapy (cart) has transformed the lives of people living with hiv. studies suggest that treatment with cart might lead to the normal to near-normal life expectancy. over the past decade our understanding of the toxic effects of cart has improved and new, convenient, seemingly less toxic, and more tolerable antiretroviral drugs... (20 天前)
The Lancet Infectious Diseases
antiretroviral therapy (art) inhibits viral replication, allows for recovery of normal immune function, and prevents progression to aids in millions of people with hiv. however, if inhibition of viral replication is incomplete, the residual antiviral pressure will select for drug-resistant virus although drug regimens are designed to prevent these outcom... (20 天前)
The Lancet Infectious Diseases
2012 will mark the 24th year of who's global poliomyelitis eradication initiative. eradication has proven more difficult than originally envisioned because of geopolitical events, such as war, social disruption, and political indifference; social and cultural issues, such as distrust of poliovirus vaccines and vaccinators; and the unanticipated emergence... (20 天前)
The Lancet Infectious Diseases
in the lancet infectious diseases, jacqueline tate and colleagues assess more than 40 reports published between 2008 and 2011 and recent data from who-coordinated global surveillance networks, which established the rate of rotavirus-associated acute gastroenteritis in children younger than 5 years who were admitted to hospital in various parts of the wor... (20 天前)
The Lancet Infectious Diseases
the field of infection control is devoted to reducing the spread of pathogens. over the years, this endeavour has developed along two distinct lines. in resource-limited communities, as shown by curtis and colleagues in their recent review, simple hygienic measures can have a remarkable effect on decreasing transmission, although their implementation may... (20 天前)
The Lancet Infectious Diseases
we are entering a new phase in the strategic use of antiretroviral drugs. in addition to dramatically reducing hiv/aids-related morbidity and mortality, these drugs have recently shown an important effect in reducing hiv incidence and transmission.... (20 天前)
订阅者 ( 1 )
martin
相关订阅源
RSS Steve Rubel

Observations, musings and insights on the future of media from Steve Rubel, EVP/Global Strategy and Insights for Edelman.

标签: web2.0 web2 micro

指数 | 29人订阅  

RSS TechCrunch

TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is written by

标签: techcrunch tech it web2.0 2.0

指数 | 519人订阅  

RSS Prostate Cancer and Prostatic Diseases - AOP - nature.com scienc

Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate.

指数 | 3人订阅  

RSS The Lancet Oncology

the lancet oncology rss feed: current issue. the lancet oncology, impact factor 9.608, considers high-quality original research, reviews, and opinion pieces in any area of clinical or translational oncology that have potential to substantially improve clinical practice. submissions judged eligible for our fast-track service are peer-reviewed in 72h, and, if accepted, published in 4-8 weeks.

指数 | 2人订阅  

我要反馈